Disclosures
Massimo Pandolfo, MD, FAAN
Scientific Advisory Boards | |
(1) Voyager Therapeutics, Scientific Advisory Board (2) Biomarin, Scientific Advisory Board (3) Minoryx, Scientific Advisory Board | |
Editorial Boards | |
(1) Acta Neurologica Belgica, Editorial Board Member, 2011- (2) Orphanet Journal of Rare Diseases, Editorial Board Member, 2013- (3) Neurology Genetics, Associate Editor, 2015-, Deputy Editor, 2018- | |
Patents | |
(1) Direct molecular diagnosis of Friedreich's ataxia. M. Pandolfo, L. Montermini, M.D.L. Molto, M. Koenig, V. Campuzano, M. Cossée. US patent (2000) 6, 150, 091, WO patent (1997) 9705234. | |
Consultancies | |
(1) Chiesi Canada | |
Research Support, Commercial Entities | |
(1) Biomarin (2) Voyager Therapeutics | |
Research Support, Government Entities | |
(1) Fonds National de la Recherche Scientifique (Belgium) | |
Research Support, Foundations and Societies | |
(1) Offrez-moi-la-lune (2) Friedreich's Ataxia Research Alliance (3) Euroataxia | |
Stock/Stock Options/Board of Directors Compensation | |
(1) Voyager Therapeutics | |
Royalty Payments, Technology or Inventions | |
(1) Friedreich's ataxia diagnostic test, Athena Diagnostics, since 1997 |